MoonLake Immunotherapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade MoonLake Immunotherapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MLTX
Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases.
CEOJorge Santos da Silva
CEOJorge Santos da Silva
Employees100
Employees100
HeadquartersZug, Zug
HeadquartersZug, Zug
Founded2021
Founded2021
Employees100
Employees100
MLTX Key Statistics
Market cap2.37B
Market cap2.37B
Price-Earnings ratio-16.06
Price-Earnings ratio-16.06
Dividend yield—
Dividend yield—
Average volume380.79K
Average volume380.79K
High today$39.50
High today$39.50
Low today$36.35
Low today$36.35
Open price$39.46
Open price$39.46
Volume266.36K
Volume266.36K
52 Week high$58.26
52 Week high$58.26
52 Week low$31.42
52 Week low$31.42
Analyst ratings
94%
of 17 ratingsBuy
94.1%
Hold
5.9%
Sell
0%
People also own
Based on the portfolios of people who own MLTX. This list is generated using Robinhood data, and it’s not a recommendation.